CV Risk Reduction in T2D: Establishing Treatment Goals

Preventing #Kidney Failure With Therapeutic Advancements in IgA #Nephropathy

Melinda Gooderham, MD: Effects of Roflumilast Foam on Scalp, Body Psoriasis

Explaining Sparsentan’s Full FDA Approval and Other IgA Nephropathy Therapeutic Developments

New Insight: A Look at Corneal Transplant Alternatives w/ John Sheets, PhD

Insights Into Semaglutide and Psychiatric Safety with Thomas A. Wadden, PhD

Michael Liebowitz, MD: PH94B Shows Promise Treating Anxiety

Michael Liebowitz, MD: The Mental Health Impact of COVID-19

Stuart Green, MD: Treating Chronic Cough

Ashley Crew, MD: The Intersection of Dermatology and Rheumatology

Mark Levy, FRCGP: Teaching Asthma Patients Better Inhaler Techniques

Brian Ference, MD, MPhil, MSc: A New Lifetime Risk Equation for Cardiovascular Disease Risk

Jeff Stark, MD: Diagnosing nr-ax-SpA

Esketamine as Treatment for Major Depressive Disorder

Erica Brenner, MD: What We've Learned about IBD Patients with COVID-19

Voxelotor in Sickle Cell Disease

The Burdens of Nonproliferative Diabetic Retinopathy

Aflibercept Injection for Nonproliferative Diabetic Retinopathy

Christopher Cannon, MD: VERTIS-CV and Ertugliflozin

Christopher Sorli, MD: Basal Insulin and GLP-1 for Type 2 Diabetes

Pulmonary Fibrosis and COVID-19 Risk

Philip Mease, MD: The Relationship Between Psoriatic Arthritis and IBD

Derm Clinical Updates: Keeping Up With COVID-19 Webinar

Biree Andemariam, MD: Sickle Cell Disease and COVID-19

How COVID-19 Has Changed Healthcare Innovation, Priorities